It is possible that the “wildtype” tumors in these studies had beta-catenin mutations in a small minority of tumor cells, and instead the better prognosis in “wildtype” tumors could be related to a lower mutant tumor cell burden. The gene discussed is CTNNB1; the disease is neoplasm.